This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Data Driven, Hybrid & Full Decentralized Clinical Trials
Mark Your Calendar for Data Driven, Hybrid and Full Decentralized Clinical Trials 2024!
In-Person Event: April 16 - 17, 2024Hilton Philadelphia at Penn's Landing, Philadelphia

Joseph A. DiMasi
Director of Economic Analysis and Research Associate Professor at Tufts Center for the Study of Drug Development, Tufts Medical School, Tufts University


Dr. DiMasi is Director of Economic Analysis at the Tufts Center for the Study of Drug Development and Research Associate Professor at Tufts Medical School, Tufts University. He is an internationally recognized expert on the economics of the pharmaceutical industry. Dr. DiMasi serves on the editorial board of Therapeutic Innovation and Regulatory Science, and has served on the editorial boards of the Journal of Research in Pharmaceutical Economics, and the Journal of Pharmaceutical Finance, Economics & Policy. He is also a member of the Board of Directors for the Phase 0 / Microdosing Network. Dr. DiMasi testified before the U.S. Congress in hearings leading up to the FDA Modernization Act of 1997 and reauthorization of the Prescription Drug User Fee Act. Dr. DiMasi’s research interests include the R&D cost of new drug development, risks in new drug development, factors that affect the length of the development and regulatory approval processes, innovation incentives for biopharmaceutical R&D, and changes in the structure and performance of the pharmaceutical and biotechnology industries.

Agenda Sessions

  • Assessing the Financial Value of Decentralized Clinical Trials